Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor-specific immunogenicity induced by chemical modification

A E Eggers

    Journal of the National Cancer Institute
    |April 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A chronic dysfunctional stress response can cause stroke by stimulating platelet activation, migraine, and hypertension.

    Medical hypotheses·2005
    Same author

    Neurological theory of hypertension.

    Medical hypotheses·2003
    Same author

    New neural theory of migraine.

    Medical hypotheses·2001
    Same author

    Antiglioma cytotoxic immune response.

    Journal of neurosurgery·1994
    Same author

    Intralymphatic immunotherapy of glioblastoma.

    New York state journal of medicine·1992
    Same author

    Induction of anti-idiotypic antibodies to a myeloma protein linked covalently to muramyl dipeptide.

    Journal of immunological methods·1990

    Immunizing spleen cells against modified tumor cells induced specific immune responses. This demonstrates a method for generating tumor-specific cytotoxic T lymphocytes against 3-methylcholanthrene-induced sarcomas.

    Area of Science:

    • Immunology
    • Oncology
    • Cancer Research

    Background:

    • 3-methylcholanthrene-induced sarcomas are a type of cancer that can be studied in mice.
    • Developing effective cancer immunotherapies is a critical area of research.
    • Understanding tumor-specific immune responses is key to designing new treatments.

    Purpose of the Study:

    • To investigate the generation of tumor-specific cytotoxic T lymphocytes (CTLs) in vitro.
    • To determine if modifying tumor cells can enhance the immune response against them.
    • To assess the specificity of the induced immune response.

    Main Methods:

    • C57BL/6J mouse spleen cells were immunized in vitro with syngeneic 3-methylcholanthrene-induced sarcoma cells.
    • Tumor cells were either modified with diazotized sulfanilic acid or left unmodified.

    Related Experiment Videos

  • Spleen cells were harvested after 5 days and tested for cytotoxicity in a 51Cr-release assay against unmodified tumor cells.

    • Main Results:

    • Spleen cells sensitized against modified tumor cells exhibited cytotoxicity against unmodified tumor targets.
    • The cytotoxic response was specific, as sensitized cells did not target other syngeneic tumor cell lines or spleen cells.
    • Spleen cells immunized against unmodified tumor cells did not show significant cytotoxicity.

    Conclusions:

    • In vitro immunization with modified tumor cells effectively generates tumor-specific cytotoxic T lymphocytes.
    • Diazotized sulfanilic acid modification of tumor cells can enhance the induction of a specific anti-tumor immune response.
    • This approach shows promise for developing targeted immunotherapies against specific sarcomas.